
    
      1. To define the hemodynamic, neurohormonal and renal responses to intravenous conivaptan
           in patients with chronic stable heart failure (HF), and compare these responses to those
           after intravenous furosemide.

        2. To define the hemodynamic, neurohormonal and renal responses to the combination of the
           two drugs (conivaptan and furosemide).
    
  